← All organizations
Highest phase reached
Phase 4
First clinical trial
Nov 1, 2011Last known activity
Mar 10, 2026
Timeline
No events for the selected filters.
Drugs by trial phase (9 distinct, 7 trials)
Phase 4 (1 own, 0 via acquisition)
Phase 3 (3 own, 0 via acquisition)
Phase 2 (2 own, 0 via acquisition)
Other trials (3 own, 0 via acquisition)
Indications
Studied for
Recent trials (10)
- NCT07275996Lead sponsorN/AMar 10, 2026
- NCT07275996Sponsor investigatorN/AMar 10, 2026
- NCT07275996OfficialN/AMar 10, 2026
- NCT05878106CollaboratorN/AJan 8, 2024
- NCT05781243CollaboratorPhase 4Jun 19, 2023
- NCT07017582Lead sponsorN/AFeb 1, 2023
- NCT07017582Sponsor investigatorN/AFeb 1, 2023
- NCT04898283Overall official - principal investigatorPhase 3May 31, 2021
- NCT01986127Overall official - principal investigatorPhase 3Feb 1, 2014
- NCT01744249Overall official - principal investigatorPhase 2Nov 1, 2011
Details
- Last known activity
- Mar 10, 2026